SLU Researcher Reports Improvements in Survival Rates in Patients with Metastatic Prostate Cancer
ST. LOUIS — Research from Saint Louis University School of Medicine finds improvements in survival in both veterans and men across the country over the last 20 years in metastatic prostate cancer, which correlates with new hormonal treatments.
Martin Schoen, M.D., assistant professor of medicine and a member of the Saint Louis University AHEAD Institute, quantified trends in overall survival among men newly diagnosed with metastatic prostate cancer and has revealed his findings in a recent research letter in JAMA Network Open.
Martin Schoen, M.D., assistant professor of medicine and a member of the Saint Louis University AHEAD Institute. Photo by Sarah Conroy.
Metastatic prostate cancer accounts for 5–10% of all prostate cancer diagnoses, but it is responsible for nearly 50% of prostate cancer-related deaths. Since 2015, the prognosis of metastatic prostate cancer has improved with the introduction of new hormonal treatment and chemotherapy combined with androgen deprivation therapy in the first-line setting.
“In the last 10 years, several new therapies have been created that have made a dramatic impact in clinical trials,” said Schoen, lead author of the study. “We wanted to study this in the general population to assess whether these breakthroughs were making its way to them.”
The study reviewed two national datasets to identify the health outcomes of men with prostate cancer, one of the most common cancers in veterans. The cross-sectional retrospective study included male patients first diagnosed with prostate cancer between the years 2000-2019. Schoen and his team analyzed datasets of 58,859 men from SEER (Surveillance, Epidemiology, and End Results) and 14,904 men from the Veterans Affairs Central Cancer Registry (VACCR).
The SEER Program of the National Cancer Institute (NCI) collects and publishes cancer incidence and survival data from population-based cancer registries covering about 48% of the U.S. population. The VACCR collects cancer diagnosis and treatment information from the 132 VA Medical Centers that treat veterans with cancer.
The study focused on the survival of men in different age groups. Schoen and the research team found that the median overall survival in patients younger than 70 significantly improved in the U.S. population from 2000 to 2019. Still, there was little change in men over 70 during the same period.
The study also found that overall survival rates were similar in SEER and VHA. Schoen, a Navy veteran who works as a hematologist/oncologist at St. Louis Veterans Affairs Medical Center, said he was pleased the data showed that in prostate cancer care, veteran care is as good or better than the treatment men receive in the general community.
The study notes that while new treatments are available and increased overall survival has been observed in clinical trials, researchers cannot assume these developments improve disease management in clinical practice. The overall survival of men with metastatic prostate cancer is lower in clinical practice than in clinical trials, as patients are typically older with more health conditions.
Researchers say further study is needed as the study is limited by lack of data on men with other medical problems, such as heart disease or diabetes.
This study was supported by the Prostate Cancer Foundation Igor Tulchinsky, Robert Taubman Sandler – PCF Valor Young Investigator Award, and Department of Defense grant No. W81XWH-22-1-0602.
Additional authors include Bruce Montgomery, M.D., VA Puget Sound Healthcare System, Fred Hutchinson Cancer Center and University of Washington School of Medicine; Lukas Owens, VA Puget Sound Healthcare System and Fred Hutchinson Cancer Center; Saira Khan, Ph.D., Washington University in St. Louis School of Medicine; Kristen Sanfilippo, M.D., Washington University in St. Louis School of Medicine; and Ruth B. Etzioni, Ph.D., Fred Hutchinson Cancer Center and University of Washington School of Medicine.
Latest Newslink
- SLU History Professor Receives Fulbright Specialist Award to Create Digital Tool Focusing on Gaelic IrelandThomas Finan, Ph.D., associate professor of history at Saint Louis University, has received a Fulbright Specialist Award. He will work with colleagues at the University of Galway to create a joint database of archaeological and historical research focusing on Gaelic Ireland.
- Don't Let that Cookie Crumble: SSE Teams Build, Test Gingerbread HousesTeams of students, faculty and staff in Saint Louis University's School of Science and Engineering recently put their engineering skills to work for a December Innovation Challenge. The teams built gingerbread houses designed to stand up during a weight-loading competition.
- Dr. Edward J. Feser Named 34th President of Saint Louis UniversityFeser, a Roman Catholic, Jesuit-educated leader in higher education, will assume the SLU presidency on July 1, 2025. Feser currently serves as the provost and executive vice president of Oregon State University (OSU), a land-grant institution with more than 38,000 students, a $1.8 billion budget and $480 million annually in externally funded research.
- SLU's Newest Alums Cheered at Commencement CeremonySaturday morning, hundreds of students walked across the stage at Chaifetz Arena and joined the Billiken alumni family. Saint Louis University celebrated its Midyear Commencement on Saturday, Dec. 14, In front of a packed crowd of family members, friends, and loved ones. Those in attendance and watching at home saw the newest graduates of SLU celebrated.
- Amy E. Wright Receives Honorable Mention for MLA's Katherine Singer Kovacs PrizeSaint Louis University's Amy E. Wright, Ph.D., received an honorable mention from the Modern Language Association of America (MLA) for the Katherine Singer Kovacs Prize for an outstanding book published in English or Spanish in the field of Latin American and Spanish literature and cultures. Wright, a professor of Hispanic Studies at SLU, received the honor for her book Serial Mexico: Storytelling across Media, from Nationhood to Now, published in 2023 by Vanderbilt University Press.
- SLU Professor and Author Jonathan Sawday Wins MLA's Prestigious James Russell Lowell PrizeSaint Louis University's Jonathan Sawday, Ph.D., has received the James Russell Lowell Prize for the most outstanding book published in 2023.
